Similar articles

• Converting enzyme, angiotensin II and hypertensive disease.

  Soffer RL, Case DB. Soffer RL, et al. Am J Med. 1978 Jan;64(1):147-160. doi: 10.1016/0002-9343(78)90191-2. Am J Med. 1978. PMID: 203191 Review. No abstract available.
• Overview of the role of angiotensin inhibitors in delineating the function of the renin-angiotensin system.

  McCaa RE. McCaa RE. Prog Biochem Pharmacol. 1980;17:29-35. Prog Biochem Pharmacol. 1980. PMID: 7010367
• A new look at the hypertension problem: the role of the renin system for analysis and treatment.

  Laragh JH. Laragh JH. Compr Ther. 1985 Oct;11(10):6-17. Compr Ther. 1985. PMID: 3902342 No abstract available.
• Captopril compared with other antirenin system agents in hypertensive patients: its triphasic effects on blood pressure and its use to identify and treat the renin factor.

  Laragh JH, Case DB, Atlas SA, Sealey JE. Laragh JH, et al. Hypertension. 1980 Jul-Aug;2(4):586-93. doi: 10.1161/01.hyp.2.4.586. Hypertension. 1980. PMID: 6156900 No abstract available.
• Hypertension, the adrenal and the kidney: lessons from pharmacologic interruption of the renin-angiotensin system.

  Hollenberg NK, Williams GH. Hollenberg NK, et al. Adv Intern Med. 1980;25:327-61. Adv Intern Med. 1980. PMID: 6153859 Review. No abstract available.